Advertisement

Advertisement

Most Read Stories
Effect of Microsatellite Instability and Tumor Mutational Burden on Outcome in First-Line Treatment of Metastatic Colorectal Cancer
Neratinib Plus Capecitabine Active Against HER2-Positive Breast Cancer Brain Metastases
FDA Approves Atezolizumab for Extensive-Stage Small Cell Lung Cancer
Effect of Medical Cannabis on Symptom Control in Patients With Cancer
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
Number of Pregnancies May Influence Breast Cancer Risk in Women With BRCA Mutations
EAU 2019: Testosterone Replacement Therapy May Slow Recurrence in Low-Risk Prostate Cancer
Use of Specialized PET/CT to Assess Estrogen Receptor Status in Recurrent or Metastatic Breast Cancer
Artificial Intelligence vs Radiologists in Breast Cancer Detection With Digital Mammography
Opioid Use Among Older Survivors of Colorectal, Lung, and Breast Cancers
SABCS 2018: Delayed Initiation of Adjuvant Chemotherapy Associated With Worse Outcomes in Patients With Triple-Negative Breast Cancer
SGO 2019: Dendritic Cell–Based Immunotherapy in Combination With Chemotherapy in Recurrent Ovarian Cancer
Validation Study of Several Models of Breast Cancer Risk
SGO 2019: Treatment With Maintenance Niraparib in Recurrent Ovarian Cancer Extends Time Without Symptoms or Toxicity
ASH 2018: Apixaban for the Treatment of Cancer-Associated VTE
AR-V7 Assay Findings and Outcomes With Hormone Therapy in High-Risk Castration-Resistant Prostate Cancer
SABCS 2018: KATHERINE Trial: Adjuvant Ado-Trastuzumab Emtansine vs Trastuzumab in Early-Stage HER2-Positive Breast Cancer
How I Work up the Patient with Thrombocytosis
Activity of Cabozantinib in Advanced Non–Clear Cell Renal Cell Carcinoma

Advertisement

Advertisement



;
Advertisement